Login / Signup

CSF biomarkers of neuronal/glial damage or immune activation are unsuitable for assessing post-COVID cognitive impairment.

Finsterer Josef
Published in: The Journal of infectious diseases (2023)
Keyphrases
  • cognitive impairment
  • coronavirus disease
  • sars cov
  • oxidative stress
  • neuropathic pain
  • cerebral ischemia
  • spinal cord
  • spinal cord injury
  • blood brain barrier
  • subarachnoid hemorrhage